Publication | Closed Access

The ω‐conopeptide SNX‐111, an N‐type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia

Focal IschaemiaSynaptic SignalingCerebral Vascular RegulationNeuroinflammationBrain DamageBrain InjuryNeurologyIschemic SyndromeHealth SciencesIon ChannelsNeuropharmacologyNeuroprotectionω‐Conopeptide Snx‐111Cerebral Blood FlowNeurophysiologyPhysiologyNeuroscienceCentral Nervous SystemMedicine